LBX(SH:603883) Xin Lang Cai Jing·2026-01-16 01:41Group 1 - The core viewpoint of the news is that Lao Bai Xing's stock performance shows a mixed trend with a slight increase in stock price but a decrease in financing activities and profitability [1][2] Group 2 - As of January 15, Lao Bai Xing's stock price increased by 0.50%, with a trading volume of 362 million yuan [1] - The financing buy-in amount on January 15 was 32.83 million yuan, while the financing repayment was 35.27 million yuan, resulting in a net financing outflow of 2.43 million yuan [1] - The total financing and securities lending balance for Lao Bai Xing reached 457 million yuan, with the financing balance accounting for 3.72% of the circulating market value, indicating a low level compared to the past year [1] Group 3 - As of October 31, the number of shareholders for Lao Bai Xing increased to 63,700, while the average circulating shares per person decreased by 1.90% to 11,921 shares [2] - For the period from January to September 2025, Lao Bai Xing reported an operating income of 16.07 billion yuan, a year-on-year decrease of 1.00%, and a net profit attributable to shareholders of 529 million yuan, down 16.11% year-on-year [2] - Since its A-share listing, Lao Bai Xing has distributed a total of 2.175 billion yuan in dividends, with 1.097 billion yuan distributed in the last three years [2] Group 4 - As of September 30, 2025, the fifth largest circulating shareholder of Lao Bai Xing was Hong Kong Central Clearing Limited, holding 7.7558 million shares, a decrease of 7.3246 million shares from the previous period [2] - The seventh largest circulating shareholder was Southern CSI 1000 ETF, holding 3.4744 million shares, down by 48,900 shares compared to the previous period [2] - The tenth largest circulating shareholder was Guotai Medical Health Stock A, holding 2.2618 million shares, a decrease of 27,900 shares from the previous period [2]